Multiple sclerosis (MS) is an autoimmune disease resulting in damage to myelin – the insulating covers of nerve cells – in the brain and spinal cord. As...

Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying...

organization dedicated to supporting individuals affected by multiple sclerosis (MS) and funding research to find a cure for the disease. They provide resources...

Current standards for diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration)...

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist,...

active in the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), delivering the 2022 ECTRIMS lecture. Banwell was born in Winnipeg...

Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia)...

Tumefactive multiple sclerosis is a condition in which the central nervous system of a person has multiple demyelinating lesions with atypical characteristics...

Multiple sclerosis is an inflammatory demyelinating disease of the CNS in which activated immune cells invade the central nervous system and cause inflammation...

notable people with multiple sclerosis. Multiple sclerosis is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal...

Malignant multiple sclerosis is used to describe MS patients who reach significant level of disability in a short period of time. Malignant MS cases are...

of multiple sclerosis organizations in different countries around the world. Multiple Sclerosis International Federation European Multiple Sclerosis Platform...

Multiple sclerosis (MS) can be pathologically defined as the presence of distributed glial scars (scleroses) in the central nervous system that must show...

biomarkers for diagnosis of multiple sclerosis, disease evolution and response to medication (current or expected) are under research. While most of them are...

The Multiple Sclerosis Society (MS Society) is the UK's largest charity for people affected by multiple sclerosis (MS). Based in London, it has offices...

There are several ways for pharmaceuticals for treating multiple sclerosis (MS) to reach the market. Novel pharmaceuticals cannot enter the US market without...

Multiple Sclerosis Australia, or MS Australia, is a national non-profit organization in Australia that coordinates and allocates funds for multiple sclerosis...

often grouped together under Multiple Sclerosis. They are sometimes considered different diseases from Multiple Sclerosis, but considered by others to...

The Multiple Sclerosis Journal (formerly Multiple Sclerosis) is a monthly peer-reviewed medical journal covering the clinical neurology of multiple sclerosis...

Multiple Sclerosis Functional Composite (MSFC) is a clinical trial outcome measure of assessing the severity of multiple sclerosis primarily used in research...

information for anyone affected by multiple sclerosis, education programmes for health professionals, funding for practical research and campaigns for specialist...

changes in the normal appearing white matter (the myelinated axons) of deceased people with multiple sclerosis. Nicole Schaeren-Wiemers discovered that in normal...

Concerts were a series of charitable rock concerts in support of Action into Research for Multiple Sclerosis in 1983. The first (and initially planned to be...

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) or—in the United States—Lou Gehrig's disease (LGD), is a rare, terminal...

British neurologist who pioneered research into multiple sclerosis. His book Multiple sclerosis, published first time in 1955, has since his death been published...

the irreversible effects of multiple sclerosis. Using what is known about the axotomy response, doctors and researchers are looking to implement neuro-protective...

similar to aggressive forms of multiple sclerosis. Although historically considered rare, with fewer than 1% of multiple sclerosis cases showing the characteristic...

Multiple Sclerosis Discovery Forum (MSDF) is a non-profit online resource created to speed progress toward a cure for multiple sclerosis (MS) and other...

The Multiple Sclerosis International Federation (MSIF) was established in 1967 as an international body linking the activities of various national MS...

Multiple sclerosis and other demyelinating diseases of the central nervous system (CNS) produce lesions (demyelinated areas in the CNS) and glial scars...